A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)
Titel:
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)
Auteur:
Platt, Heather L. Cardona, Jose F. Haranaka, Miwa Schwartz, Howard I. Narejos Perez, Silvia Dowell, Anthony Chang, Chih-Jen Dagan, Ron Tamms, Gretchen M. Sterling, Tina Morgan, Leslie Shi, Yaru Pedley, Alison Musey, Luwy K. Buchwald, Ulrike K.